Trial intelligence / Profile preview

Phase IIa trial of KindaPed lotion for treatment of head lice

2005-005512-24Phase 2Completed

Sponsor
EctoPharma
Start
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of KindaPed in pediculosis capitis, sponsored by EctoPharma. Primary endpoint: Cure or re-infestation status. Started Apr 2006; status: completed.

02

Drugs

KindaPed
03

Conditions

pediculosis capitis

Beyond the preview

Go deeper on 2005-005512-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005512-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call